✨ Free AI Report
Bayer Aktiengesellschaft: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Bayer Aktiengesellschaft
Company Research

Bayer Aktiengesellschaft: Business Overview, Financials & Competitive Analysis

Bayer is a German healthcare and agriculture conglomerate where healthcare provides close to half the company's sales including pharmaceutical drugs, vitamins, and consumer healthcare products, while its crop science ...

Analyst-debate audio for Bayer Aktiengesellschaft

AskCyborg analysts argue the bull and bear cases for Bayer Aktiengesellschaft across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Bayer represents a recovery play with turnaround potential driven by pharmaceutical innovation and operational restructuring,...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Agriculture / Life Sciences Conglomerate
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Bayer Aktiengesellschaft Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Bayer Aktiengesellschaft Overview

Pro stress-test →

Bayer is a German healthcare and agriculture conglomerate where healthcare provides close to half the company's sales including pharmaceutical drugs, vitamins, and consumer healthcare products, while its crop science business sells seeds, pesticides, herbicides, and fungicides. The firm expanded through its 2018 acquisition of Monsanto. The company has a current market capitalization of $47.7B.

Strategic Profile

Pro stress-test →

Bayer's stock has recovered significantly, with BofA Securities raising its 12-month price target to €55 from €35 following greater confidence after a U.S. Supreme Court development related to glyphosate litigation. The company projects a return to profit growth from 2026 onwards driven by a robust pharmaceutical pipeline, crop science optimizations, and internal restructuring aimed at significant savings.

Competitive Landscape

Pro stress-test →

Bayer competes with multinational pharmaceutical companies including Novartis. In pharmaceuticals, Bayer faces competition from Roche, Merck, and other major pharma firms. In crop science and agricultural inputs, competitors include Corteva Agriscience, BASF, and other specialty chemical companies. Bayer's diversified portfolio across pharmaceuticals, consumer health, and crop science provides competitive advantages in integrated life sciences solutions.

Industry Context

Bayer Aktiengesellschaft operates in Pharmaceuticals & Agriculture / Life Sciences Conglomerate.

Key facts

Founded: 1863 · Headquarters: Leverkusen, Germany · Employees: 102,000 · Revenue: $50.6B · Market cap: $47.7B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Bayer Aktiengesellschaft.

  • Stock price recovery of ~90% from 2024 lows, trading near €45 in February 2026 after reaching €19-22 range in early 2025
  • Strong pharmaceutical pipeline with new product launches positioned to offset patent expirations and drive sustainable growth
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026U.S. Supreme Court development related to glyphosate litigation driving analyst price target upgrades
  • June 2025Later stage VC deal with Ukko signaling continued investment in emerging opportunities
  • +1 moreTrack every material event for Bayer Aktiengesellschaft as it happens. Explore monitoring →
Get alerted when Bayer Aktiengesellschaft has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

PharmaceuticalsSwiss multinational pharma competitor→PharmaceuticalsLeading global healthcare and diagnostics company→PharmaceuticalsMajor multinational pharmaceutical company→Crop ScienceAgricultural inputs and seeds competitor→

Compare Bayer Aktiengesellschaft with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Bayer Aktiengesellschaft operates in Pharmaceuticals & Agriculture / Life Sciences Conglomerate. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Agriculture / Life Sciences Conglomerate research →
NEW · MCP server

Ask your AI assistant about Bayer Aktiengesellschaft

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Bayer Aktiengesellschaft and its top competitor on Cyborg Score”
“What did Bayer Aktiengesellschaft do this quarter?”
“Is Bayer Aktiengesellschaft a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Bayer Aktiengesellschaft do?+
Bayer is a German healthcare and agriculture conglomerate where healthcare provides close to half the company's sales including pharmaceutical drugs, vitamins, and consumer healthcare products, while its crop science ...
What is Bayer Aktiengesellschaft's Cyborg Score?+
Bayer Aktiengesellschaft has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Bayer Aktiengesellschaft's main competitors?+
Named competitors include Pharmaceuticals, Pharmaceuticals, Pharmaceuticals, Crop Science. The full competitive landscape is in the AskCyborg report.
How can I get the full Bayer Aktiengesellschaft research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Bayer Aktiengesellschaft research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Bayer Aktiengesellschaft over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.